Radisens is transforming clinical diagnostics through its integrated near-patient device for high-burden chronic disease diagnosis and monitoring. Find out about this high growth diagnostics market, or learn more about our Gemini™ platform and breakthrough patent-pending technologies.
No other solution on the market delivers on the unmet clinical need to instantly test for any disease or medical condition at the point of care. Using a fraction of a blood drop, the Gemini™ platform offers a single device for decentralized diagnostics. Placement in physicians' offices, pharmacies or medical clinics will realize unprecedented patient access, improved outcomes and healthcare efficiencies.
Radisens' market traction and strategic partnerships is testament to our disruptive patent-pending technology, extensive intellectual property portfolio and unique value proposition.
Radisens' disruptive Gemini™ platform introduces multiple patent-pending technologies into an integrated near-patient device, starting with the toughest tests. Requiring a fraction of a drop of blood, this multi-mode device instantly tests for high-burden chronic disease with laboratory-grade performance.
As the only near-patient device with such a broad blood testing menu, instant diagnosis and monitoring with Gemini™ improves patient outcomes and increases healthcare efficiencies. By applying a finger-prick of patient's blood, the physician simply inserts the cartridge into the device, for instant results.